FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

704226002: Pertuzumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2015. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3012148012 Pertuzumab en Synonym Active Entire term case insensitive SNOMED CT core module
3012447013 Pertuzumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pertuzumab Is a Monoclonal antibody agent false Inferred relationship Existential restriction modifier
Pertuzumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Pertuzumab Is a Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier
Pertuzumab Has disposition Human epidermal growth factor receptor 2 inhibitor true Inferred relationship Existential restriction modifier
Pertuzumab Is a Antineoplastic agent false Inferred relationship Existential restriction modifier
Pertuzumab Is a Enzyme inhibitor protein true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Pertuzumab 30mg/mL solution for injection Has active ingredient False Pertuzumab Inferred relationship Existential restriction modifier
Product containing pertuzumab Has active ingredient True Pertuzumab Inferred relationship Existential restriction modifier 1
Pertuzumab Has active ingredient True Pertuzumab Inferred relationship Existential restriction modifier 1
Product containing pertuzumab in parenteral dose form (medicinal product form) Has active ingredient True Pertuzumab Inferred relationship Existential restriction modifier 1
Product containing only pertuzumab in parenteral dose form (medicinal product form) Has active ingredient True Pertuzumab Inferred relationship Existential restriction modifier 1
Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) 1 vial Has specific active ingredient True Pertuzumab Inferred relationship Existential restriction modifier
Pertuzumab 1.2g/15ml / Trastuzumab 600mg/15ml solution for injection vials 1 vial Has specific active ingredient True Pertuzumab Inferred relationship Existential restriction modifier
Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) Has specific active ingredient True Pertuzumab Inferred relationship Existential restriction modifier
Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) Has specific active ingredient True Pertuzumab Inferred relationship Existential restriction modifier
Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials 1 vial Has specific active ingredient True Pertuzumab Inferred relationship Existential restriction modifier
Pertuzumab 420mg/14ml solution for infusion vials Has active ingredient False Pertuzumab Inferred relationship Existential restriction modifier
Pertuzumab 1.2g/15ml / Trastuzumab 600mg/15ml solution for injection vials Has specific active ingredient True Pertuzumab Inferred relationship Existential restriction modifier
Pertuzumab 600mg/10ml / Trastuzumab 600mg/10ml solution for injection vials Has specific active ingredient True Pertuzumab Inferred relationship Existential restriction modifier
Phesgo 600mg/600mg/10ml solution for injection vials (Roche Products Ltd) 1 vial Has specific active ingredient True Pertuzumab Inferred relationship Existential restriction modifier
Perjeta 420mg/14ml concentrate for solution for infusion vials (Roche Products Ltd) Has specific active ingredient True Pertuzumab Inferred relationship Existential restriction modifier
Pertuzumab 420mg/14ml solution for infusion vials 1 vial Has specific active ingredient True Pertuzumab Inferred relationship Existential restriction modifier
Pertuzumab 420mg/14ml solution for infusion vials Has specific active ingredient True Pertuzumab Inferred relationship Existential restriction modifier
Perjeta 420mg/14ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has specific active ingredient True Pertuzumab Inferred relationship Existential restriction modifier
Perjeta 420mg/14ml concentrate for solution for infusion vials (Originalis B.V.) Has specific active ingredient True Pertuzumab Inferred relationship Existential restriction modifier
Perjeta 420mg/14ml concentrate for solution for infusion vials (Originalis B.V.) 1 vial Has specific active ingredient True Pertuzumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start